Sign in
4/A

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-012960

Options or other derivatives

  • Chief Financial Officer acquired 399,266 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
WEAVER GREGORY L Chief Financial Officer 2017-12-20 Grant or award · Employee Stock Option (Right to Buy) +399,266 399,266 D
Loading xslF345X03/doc4a.xml…